Well put. This is a welcome advance in AD treatment, but these are not the results we are ultimately going for with our approach. Hopefully our effects will represent a more significant treatment.
if amyloid plaques are both an outcome of a dementia root cause and an accelerant,
This has been discussed here many, many times. Published and academic work has also been posted here. The finding has been that Amyloid is a symptom, not a cause for AD. BTW, 30+ years of FDA approved trials have all concluded the same thing.
Market Data 
Markets 
